Latest Health News
WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 Congress and in European Journal of Heart Failure related to the DELTA-HF Study in Acute Decompensated Heart Failure
GALWAY, Ireland, May 10, 2026 (GLOBE NEWSWIRE) -- WhiteSwell, a clinical-stage medtech…
A Pint for Kim Blood Drive Breaks Illinois Record for the Seventh Year in a Row with over 650 Donations in One Day
NAPERVILLE, Ill., May 09, 2026 (GLOBE NEWSWIRE) -- A Pint for Kim,…
Open Peer-Review Exposes UPV Ethics Committees Dilemma: Suppress a 33 Year Recognized Breakthrough or Acknowledge Reviewers Ethical Violations and Remit Final Judgement to the Known Dataset Test to Save Millions of Lives and Billions of Euros
DALLAS, May 08, 2026 (GLOBE NEWSWIRE) -- In PDF (https://bit.ly/4tq29FV). The Crosetto…
Asuno Launches Sleep & Energy Patches to Address Rising Consumer Demand for Wellness Solutions
NEW YORK, May 09, 2026 (GLOBE NEWSWIRE) -- Asuno today announced the…
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
May 08, 2026 21:04 ET | Source: iSpecimen Inc. May 8, 2026…
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
May 08, 2026 20:45 ET | Source: Amplia Therapuetics Limited Melbourne, Australia,…
James Cacioppo Files Updated Early Warning Report
May 08, 2026 16:05 ET | Source: Jushi Holdings Inc. BOCA RATON,…
Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held on June 10, 2026
REGULATED INFORMATIONMay 8, 2026, 10:05pm CET / 4:05pm ET NYXOAH SA(Euronext Brussels/Nasdaq:…
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
MIAMI, May 08, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a…
